Abstract:Objective To analyze the characteristics of drug resistance to quinolones and erythromycin of clinical Campylobacter jejuni (C .jejuni) strains and to further investigate its molecular mechanisms .Methods A total of 193 clinical C .jejuni strains were isolated from feces of patients with diarrhea .Drug susceptibilities to ciprofloxacin (CIP ) , gentamycin (GEN ) , azithromycin (AZI ) , erythromycin (ERY) ,chloromycetin (CHL) ,doxycycline (DOX) and tetracycline (TET) were tested using standard agar dilution method . gyrA , gyrB and parC genes were amplified by polymerase chain reaction (RCR) and analyzed for molecular mechanisms of quinolones resistance ,and 23S rRNA , rplD and rplV genes for erythromycin resistance .Chi‐square test or Fisher′s exact two‐tailed tests were used to perform the statistical analysis .Results A total of 193 clinical C . jejuni strains were isolated during 1994—2010 ,among which 43 C .jejuni strains were isolated in 1994—1999 ,80 in 2000—2005 and 70 in 2006—2010 .The drug resistance rates for CIP increased significantly from 55 .8% in 1994—1999 to 95 .0% in 2000—2005 and 94 .3% in 2005—2010 (χ2=41 .94 ,P<0 .01) .The drug resistance rates for GEN were 0 in 1994—1999 ,11 .3% in 2000—2005 and 10 .0% in 2006—2010 ,but with no statistic difference (χ2=5 .078 , P=0 .08) .The drug resistance rates for AZI were 0 in 1994—1999 ,3 .8% in 2000—2005 and 4 .3% in 2006—2010 (χ2=1 .81 ,P=0 .40) .The drug resistance rates for ERY were 0 in 1994—1999 ,1 .3% in 2000—2005 and 4 .3% in 2006—2010 (χ2 = 2 .87 , P= 0 .24 ) . T he drug resistance rates for CHL were 2 .3% in 1994—1999 ,11 .3% in 2000—2005 and 20 .0% in 2006—2010 (χ2 =7 .82 ,P=0 .02) .The drug resistance rates for DOX were 60 .5% in 1994‐1999 ,86 .3% in 2000—2005 and 82 .9% in 2006—2010 (χ2 =12 .18 ,P<0 .01) .The drug resistance rates for TET were 74 .4%in 1994—1999 ,95 .0% in 2000—2005 and 94 .3% in 2006—2010 (χ2 = 15 .46 , P< 0 .01 ) .T he drug resistance rates for CIP‐DOX‐TET were 37 .2% in 1994—1999 ,83 .8% in 2000—2005 and 80 .0% in 2006—2010 (χ2 =33 .53 ,P<0 .01) .The drug resistance rates for CHL‐CIP‐DOX‐TET were 0 in 1994—1999 ,7 .5% in 2000—2005 and 20 .0% in 2006—2010 (χ2=12 .68 ,P<0 .01) .The drug resistance rates for GEN‐CIP‐DOX‐TET were 0 in 1994—1999 ,7 .5% in 2000—2005 and 8 .6% in 2006—2010 (χ2 =3 .74 ,P=0 .15) .All 163 CIP‐resistant C .jejuni strains had C257T mutation on gyrA gene .Mutations on gyrB gene were silent .ParC gene was absent in C .jejuni .Four ERY resistant C .jejuni strains had no mutation on rplD and rplV genes , but 3 of them had A2075G mutation on 23S rRNA gene . Conclusions The antimicrobial resistance rates for C .jejuni increase remarkably over the periods .C257T mutation on gyrA gene and A2075G mutation on 23S rRNA gene are main mechanisms for quinolones resistance and erythromycin resistance ,respectively .

Three cases of acute gastroenteritis caused by high-level macrolideresistant Campylobacter: drug resistance mechanisms and clinical characteristics.

Genome Assessment of Carbapenem- and Colistin-Resistant Escherichia Coli from Patients in a Sentinel Hospital in China.

Molecular Characteristics of Extended-Spectrum Β-Lactamase-producing Escherichia Coli and Klebsiella Pneumoniae Causing Intra-Abdominal Infections from 9 Tertiary Hospitals in China

Complete Genomic Characterization of Two Escherichia Coli Lineages Responsible for a Cluster of Carbapenem-Resistant Infections in a Chinese Hospital

Clinical features and drug resistance in patients with acute Campylobacter jejuni-induced enteritis

A Seventeen-Year Observation of the Antimicrobial Susceptibility of Clinical Campylobacter Jejuni and the Molecular Mechanisms of Erythromycin-Resistant Isolates in Beijing, China

Laboratory Study on the Gastroenteritis Outbreak Caused by a Multidrug-Resistant Campylobacter coli in China

Genotypic Diversity And Epidemiology Of High-Level Gentamicin Resistant Enterococcus In A Chinese Hospital

The Drug Resistance and Molecular Mechanisms of Human Campylobacter Jejuni

Antimicrobial resistance in Campylobacter coli and Campylobacter jejuni from human campylobacteriosis in Taiwan, 2016–2019

Gene expression profile of Campylobacter jejuni in response to macrolide antibiotics

Whole-Genome and Plasmid Comparative Analysis of Campylobacter jejuni from Human Patients in Toyama, Japan, from 2015 to 2019

Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates

Susceptibility Testing 200 Strains of Campylobacter to Antibacterials

Clinical and microbiological findings of recurrent Campylobacter spp. gastroenteritis in a tertiary care hospital

Adaptive mechanisms of Campylobacter jejuni to erythromycin treatment

Antibiotic Susceptibilities and Genetic Variations in Macrolide Resistance Genes of Ureaplasma Spp. Isolated in China.

Comparative genomic sequencing to characterize Mycoplasma pneumoniae genome, typing, and drug resistance

Identification of Campylobacter jejuni and determination of point mutations associated with macrolide resistance using a multiplex TaqMan MGB real-time PCR.

Multi-drug and β-lactam resistance in Escherichia coli and food-borne pathogens

Molecular Characterization, Antimicrobial Resistance And Caco-2 Cell Invasion Potential Of Campylobacter Jejuni/Coli From Young Children With Diarrhea